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Among the many neuromodulators used by the mammalian brain to regulate circuit function and plasticity,
dopamine (DA) stands out as one of the most behaviorally powerful. Perturbations of DA signaling are
implicated in the pathogenesis or exploited in the treatment of many neuropsychiatric diseases, including
Parkinson’s disease (PD), addiction, schizophrenia, obsessive compulsive disorder, and Tourette’s
syndrome. Although the precise mechanisms employed by DA to exert its control over behavior are not fully
understood, DA is known to regulate many electrical and biochemical aspects of neuronal function including
excitability, synaptic transmission, integration and plasticity, protein trafficking, and gene transcription.
In this Review, we discuss the actions of DA on ionic and synaptic signaling in neurons of the prefrontal cortex
and striatum, brain areas in which dopaminergic dysfunction is thought to be central to disease.Introduction
Dopamine (DA) is a catecholamine (CA) that was initially identi-
fied as the metabolic precursor of the neurotransmitter norepi-
nephrine (NE). Pioneering studies by Arvid Carlsson in the late
1950s first lent support to the idea that DA does not merely serve
as an intermediate for NE biosynthesis, but rather functions as
a transmitter in the mammalian CNS in its own right (Carlsson
et al., 1957, 1958; Carlsson, 1959). Since that time, neuroscien-
tists have sought to elucidate the influence that DA exerts on
behavior and neural circuits and to uncover the underlying
cellular and molecular underpinnings of such effects. Interest
in the actions of this molecule is further stimulated by the recog-
nition of its involvement in several neurological and psychiatric
disorders, including Parkinson’s disease (PD), addiction,
schizophrenia, obsessive compulsive disorder, and Tourette’s
syndrome. DA plays an important role in the control of fine
motor actions and higher cognitive functions such as learning,
working memory, attention, decision making, and appetitive
and consummatory aspects of reward. However, the precise
mechanisms employed by DA to mediate these effects remain
largely unknown owing to the multiplicity and complexity of its
actions. DA signaling involves a plethora of molecules including
kinases, phosphatases, transcription factors, ion channels, and
membrane receptors. Moreover, DA’s actions have largely
defied interpretation because they vary greatly between cell
types, depend on the strength and duration of receptor stimu-
lation, are influenced by current and past cellular states, and
compete with other neuromodulatory systems impinging on
similar pathways. Thus, despite extensive investigation, there
is no unified view of dopamine’s actions in the CNS, and
many studies have yielded contradictory conclusions. Here, we
discuss dopamine’s ability to rapidly influence synaptic trans-
mission, dendritic integration, and membrane excitability.
The search for neurons that produce DA started in the early
1960s, after the remarkable finding that catecholamine-contain-
ing neurons could be visualized in tissue after chemical con-
version of CAs into fluorescent molecules with formaldehyde(Carlsson et al., 1962; Falck et al., 1982). Using this method,
seventeen groups of CA cells (designated A1–A17) were initially
identified in the CNS. Specific identification of DA-producing
cells is complex even with modern techniques. Firmly establish-
ing a dopaminergic identity necessitates the analysis of multiple
cellular markers and ideally the demonstration of stimulus-
evoked DA release from genetically defined neurons such as
by combining optogenetics and carbon fiber voltammetry (e.g.,
Stuber et al., 2010; Tecuapetla et al., 2010). Collectively, the
available data support the existence of ten DA-producing nuclei
in the mammalian brain (A8–A17). Neurons within each field
can differ significantly with respect to axonal projection areas,
electrophysiological properties, and the expression of synthetic
enzymes, membrane and vesicular transporters, neuropeptides,
and other amino acid transmitters (Bjo¨rklund and Dunnett, 2007;
Hnasko et al., 2010; Lammel et al., 2011).
Midbrain DA neurons in the substantia nigra pars compacta
(SNc; field A9) and ventral tegmental area (VTA; field A10) are
perhaps the best studied of these because of their central roles
in the pathology of PD and in reward signaling and reinforce-
ment, respectively. These two centers provide the bulk of DA
to the basal ganglia and forebrain and contain the vast majority
of DA neurons in the CNS. In the rat, VTA and SNc each contain
20,000 neurons bilaterally (German and Manaye, 1993). Given
their small numbers and powerful impact on many aspects of
behavior, each midbrain DA neuron must exert influence over
large brain areas andmany cells. Indeed, individual SNc neurons
extend impressive axons of half a meter in total length that
densely ramify throughout up to 1 mm3 of tissue (Matsuda
et al., 2009). Furthermore, midbrain DA neurons are spontane-
ously active at low frequencies, suggesting that each neuron
provides a basal DA tone to many target neurons that is rapidly
adjusted by either phasic bursts or transient pauses of activity.
Some of the first electrophysiological investigations of DA’s
influence in the 1970s and 1980s utilized in vivo and in vitro extra-
cellular and intracellular recordings and examined the effects
of electrical stimulation of DA centers or local application ofNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 33
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Figure 1. Potential Sites of Modulation of Synaptic Transmission
by DA
DA may affect neurotransmitter release by modulating axon terminal excit-
ability (a), Ca2+ influx (b), or vesicular release machinery (c). This can occur
directly, through activation of presynaptic DA receptors, or indirectly, after the
recruitment of postsynaptic DA receptors and liberation of retrograde signaling
molecules (d). Postsynaptic DA receptors may influence neurotransmitter
detection by modulating the membrane insertion (e), synaptic recruitment (f),
or properties (g) of neurotransmitter receptors. In addition, DA alters synaptic
integration and the excitability of pre- and postsynaptic membranes by
modulating ion channels that control resting potential, Ca2+ influx, and action
potential threshold and waveform (h).
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variable, and often contradictory findings (see Nicola et al.,
2000; Seamans and Yang, 2004 for review). Some of these
disparities probably arose because, as discussed below, DA
activates multiple classes of receptors that are heterogeneously
distributed and engage different intracellular signaling cascades.
Neuromodulators affect several distinct steps of synaptic
transmission, including the probability of neurotransmitter
release, the postsynaptic sensitivity to neurotransmitter, and
the membrane excitability of the pre- and postsynaptic cells
(Figure 1). These neuromodulatory targets are expected to alter
synaptic communication in different ways and should be con-
sidered separately. First, the excitability of presynaptic neurons
directly determines the frequency of activation of synapses by
controlling the rate of action potential invasion of presynaptic
boutons. Such changes may fall under the general category of
‘‘gain-control’’ mechanisms, which linearly transform the input-
output relationship of a circuit. Modulation of the excitability of
interneurons that mediate feedback and feedforward inhibition
can additionally introduce time-dependent transformations that
alter circuit activity in complex ways. Second, neuromodulators
directly regulate the probability of action potential-evoked vesic-
ular neurotransmitter release from presynaptic boutons by34 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.altering the size and properties of the vesicle pool or of the state
of active zone proteins. DA also has indirect effects on release
probability due to its impact on ion channels that determine
action potential-evoked Ca2+ influx. Alterations in release prob-
ability have complex effects on the time dependence of neuro-
transmitter release that can profoundly alter the dynamics of
action potential firing. Third, neuromodulators control the
number, classes, and properties of neurotransmitter receptors
in the synapse, thereby regulating the biochemical and elec-
trical postsynaptic response. In the simplest cases, changing
the number of synaptic ionotropic receptors is analogous to
gain control—e.g., increasing the number of synaptic AMPA-
type glutamate receptors enlarges the excitatory postsynaptic
potential (EPSP), thus altering the gain in the transformation
from pre- to postsynaptic activity. However, more subtle modes
of regulation are possible with specific changes to subsets of
neurotransmitter receptors. Downstream of neurotransmitter
receptor activation, regulation of postsynaptic ion channels
can have profound effects on the generation of synaptic poten-
tials, Ca2+ influx, synaptic integration, plasticity, and action
potential firing.
This Review will dissect the reported effects of DA on each of
three steps that broadly define synaptic transmission: presyn-
aptic neurotransmitter release, postsynaptic neurotransmitter
detection, and membrane excitability and synaptic integration.
Given space constraints, we restrict our analysis to prefrontal
cortex (PFC) and striatum, as they are the major targets of
the largest group of DA neurons in the mammalian brain and
perturbations of DA in these brain regions are implicated in the
pathogenesis of numerous neurological diseases. We limit our
presentation to studies in which pharmacological, biochemical,
or electrophysiological assays were used to specifically assign
(to the extent possible) the regulatory targets of DA to each of
these three synaptic transmission steps. We also restrict our
discussion to studies of rodents because they constitute the
model of choice for the majority of in vitro electrophysiological
studies and have significantly contributed to our understanding
of DA signaling in recent years with the application of molecular,
genetic, and optogenetic techniques.
Intracellular Signaling by DA Receptors
Once released from presynaptic terminals, DA mediates its
effects by interacting with members of a family of GPCRs (D1–
D5 receptors). These distinct but closely related DA receptors
are commonly segregated in two major classes based on their
structural, pharmacological, and signaling properties: D1 and
D5 receptors belong to the subfamily of D1-like receptors,
whereas D2, D3, and D4 receptors are grouped into the D2-
like receptor class (Table 1). The D2-like receptors are alterna-
tively spliced, giving rise to isoforms with distinct physiological
properties and subcellular localization, with the best character-
ized of these isoforms being the short and long variants of D2
receptors (D2S and D2L, respectively). Several variants of D3
and D4 receptors have also been described (Callier et al.,
2003; Rankin et al., 2010). By contrast, the genes encoding
D1-like receptors consist of a single exon and therefore do not
generate splice variants. At the protein level, receptors within
the D1- and D2-like receptor classes share a high level of
Table 1. Basic Characteristics of DA Receptors
D1-like Family D2-like Family
DA receptor subtype D1 D5 D2 D3 D4
Gene name Drd1a Drd5 Drd2 Drd3 Drd4
Number of introns 0 0 6 5 3
Splice variants No No Yes (D2S, D2L) Yes Yes
Affinity for DA (mM)* 1.0–5.0 0.2–2.0 0.2–2.0 0.02–0.2 0.01–0.1
G protein coupling Gas, Gaolf Gas, Gaq Gai, Ga0 Gai, Ga0 Gai, Ga0
Common family-specific
agonists
SKF-38393, SKF-81297 () Quinpirole, Cabergoline
Common family-specific
antagonists
SCH-23390, SKF-83566 () Sulpiride, Spiperone, Nemonapride
*RKi ranges for cloned human DA receptors obtained from the NIMH Psychoactive Drug Screening Program database (http://pdsp.med.unc.edu) and
the International Union of Basic and Clinical Pharmacology.
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Pharmacological agonists and antagonists of DA receptors can
readily distinguish between receptor families, but less so
between individual subtypes within a family. The affinity of D2-
like receptors for DA is generally reported to be 10- to 100-fold
greater than that of D1-like receptors, with D3 and D4 receptors
displaying the highest sensitivity for DA and D1 receptors the
lowest (Beaulieu and Gainetdinov, 2011). However, given that
these measurements rely on displacement of radiolabeled
antagonists from heterologously expressed DA receptors and
do not capture the coupling efficacy to downstream signaling
cascades, it is difficult to infer whether D2-like receptors are
preferentially activated by basal extracellular levels of DA in vivo.
Moreover, D1 and D2 receptors can exist in both high and low
affinity states and have similar nanomolar affinities for DA in their
high affinity states (reviewed in Wickens and Arbuthnott, 2005).
Finally, the D1- and D2-like receptor classes differ functionally
in the intracellular signaling pathways theymodulate. As GPCRs,
all DA receptors activate heterotrimeric G proteins, but the
second messenger pathways and effector proteins activated
by both receptor classes vary greatly and oftenmediate opposite
effects (Figure 2). These signaling cascades are described in
detail elsewhere (see Beaulieu and Gainetdinov, 2011; Fisone,
2010; Neve et al., 2004 and references within); only a brief over-
view is presented here.
D1-like receptors stimulate the heterotrimeric G proteins Gas
and Gaolf, which are positively coupled to adenylyl cyclase
(AC), leading to the production of cyclic adenosine monophos-
phate (cAMP) and the activation of protein kinase A (PKA). By
contrast, D2-like receptors activate Gai and Gao proteins, which
inhibit AC and limit PKA activation. PKA mediates most of the
effects of D1-like receptors by phosphorylating and regulating
the function of a wide array of cellular substrates such as
voltage-gated K+, Na+ and Ca2+ channels, ionotropic glutamate,
and GABA receptors and transcription factors. One of the major
targets of PKA is the DA and cAMP-regulated phosphoprotein
DARPP-32, which is highly expressed in DA-responsive striatal
and cortical neurons and plays a critical role in the regulation
of downstream signal transduction pathways. DARPP-32 inte-
grates signals from several neurotransmitters to bidirectionally
modulate PKA activity. When phosphorylated by PKA, DARPP-32 amplifies PKA signaling by inhibiting protein phosphatase 1
(PP1), which counteracts PKA’s actions. By contrast, dephos-
phorylation by the calmodulin-dependent protein phosphatase
2B (PP2B) upon D2-like receptor stimulation helps convert
DARPP-32 into a potent inhibitor of PKA signaling.
DA receptors can also signal independently of cAMP/PKA to
modulate intracellular Ca2+ levels and regulate ligand- and
voltage-gated ion channels. This is particularly true for Gai/0-
coupled receptors, such asmembers of the D2-like family, which
target several effector proteins through liberation of the Gbg
subunit of heterotrimeric G proteins upon receptor activation.
Membrane-bound Gbg subunits can diffuse along the plasma
membrane to directly activate ion channels or second messen-
gers. The best example is the gating of G protein-activated
inward-rectifier K+ channels (Kir3) in D2 receptor-expressing
midbrain DA neurons (Beckstead et al., 2004). Release of Gbg
subunits after D2-like receptor stimulation can also decrease
CaV2.2 (N-type) and CaV1 (L-type) Ca
2+ currents directly or indi-
rectly via activation of phospholipase C (PLC). There is also
evidence that D1-class receptors can activate PLC by coupling
toGaq heterotrimeric G proteins; but this propertymay be limited
to cells expressing D5 receptors or D1/D2 heterodimers (Lee
et al., 2004; Sahu et al., 2009). In addition to their effects on
G protein-regulated pathways, D1 and D2 receptors can alter
membrane trafficking of CaV2.2 channels as well as NMDA and
GABAA receptors through direct protein-protein interactions or
downstream of tyrosine kinase activation.
DA Receptor Distribution in Forebrain
DA receptors are broadly expressed in the CNS, with their distri-
bution and expression levels largely mirroring the density of
innervating DA fibers (see Bentivoglio and Morelli, 2005; Callier
et al., 2003 and references within). D1 and D2 receptors are
the two most abundant receptor subtypes expressed in the
brain, with D1 receptors displaying the most widespread distri-
bution and highest expression levels. D1 and D2 receptors are
most prominently found in dorsal striatum, ventral striatum
(nucleus accumbens), and olfactory tubercle, which constitute
the principal recipient structures of midbrain DA axons. D1 and
D2 receptor mRNA is also found in other forebrain structures,
including cortex. The expression of D3, D4, and D5 receptorsNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 35
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Figure 2. Intracellular DA Signaling Pathways
Schematic of cAMP/PKA-dependent (A) and -independent (B) pathways re-
cruited by DA receptors. D1- and D2-like receptors are depicted in the same
cell for illustrative purposes. Note that some of the targets of Gbg are ion
channels (Kir3, CaV1, and CaV2.2). Black and red arrows depict activation and
inhibition, respectively. IP3, inositol triphosphate; DAG, diacylglycerol.
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that of D1 and D2 receptors. D1- and D2-like receptors are
expressed in both striatal projection neurons (SPNs) and inter-
neurons, as well as in subpopulations of pyramidal neurons,
interneurons, and glial cells in cortex (Table 2). In these brain
regions and others, D1- and D2-like receptors are localized
presynaptically in nerve terminals and axonal varicosities, as
well as postsynaptically in dendritic shafts and spines (Bentivo-
glio and Morelli, 2005). Thus, no simple and general division of
labor exists between D1 and D2 receptor families with respect36 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.to receptor distribution in projection versus locally projecting
neurons or pre- versus postsynaptic membrane specializations.
Striatum is almost entirely populated by two equally sized
groups of GABAergic SPNs that extend axons either to basal
ganglia output nuclei (the striatonigral or so-called direct
pathway SPNs, denoted dSPNs) or to the external segment of
the globus pallidus (GPe) (the striatopallidal or indirect pathway
SPNs, denoted iSPNs). Anatomical, pharmacological, and
single-cell RT-PCR studies determined that dSPNs express
high levels of D1 receptors along with the peptides neurotrans-
mitter substance P and dynorphin, whereas iSPNs express D2
receptors as well as the neurotransmitter enkephalin (Gerfen,
1992; Gerfen and Surmeier, 2011). This dichotomy was recapit-
ulated in transgenic mice using bacterial artificial chromosomes
(BACs) that express Cre recombinase or fluorescent proteins
such as enhanced green fluorescent protein (EGFP) or tdTomato
under control of the promoter region for D1 or D2 receptor genes
(Ade et al., 2011; Gong et al., 2003, 2007). In these mice, trans-
genes driven by D1 and D2 receptor promoters are almost
exclusively segregated into striatonigral and striatopallidal
populations, respectively, although a small number of D1
receptor-containing dSPNs additionally extend axon collaterals
in GPe (Valjent et al., 2009), consistent with earlier anatomical
studies of single biocytin-filled cells. Moreover, molecular
profiling studies in iSPNs and dSPNs support the selective
enrichment of D1 and D2 receptors in distinct SPN populations
(Heiman et al., 2008; Lobo et al., 2010). However, some contro-
versy persists as to whether the segregation of DA receptor
families in SPNs is absolute and whether subpopulations of
SPNs potentially coexpressing both receptor types underlie
the synergistic actions of D1 and D2 receptor agonists observed
in some experimental preparations (Perreault et al., 2011).
Indeed, in situ hybridization and single-cell RT-PCR experiments
have revealed that D1 and D2 receptors can both be detected in
a subset of SPNs in striatum and that dSPNs and iSPNs also
express low levels of D3, D4, and D5 receptor mRNA (Lester
et al., 1993; Surmeier et al., 1992, 1996). It is unclear whether
these low-abundance transcripts significantly contribute to
SPN function and whether the apparent cooperative effects of
D1- and D2-like receptors observed in some studies instead
arise from complex network interactions.
By virtue of the fact that dSPNs and iSPNs share largely similar
morphological and physiological properties, they represent
an ideal system to compare the differential neuromodulatory
effects of D1 and D2 receptors on synaptic transmission and
intrinsic excitability. However, despite this seeming simplicity,
electrophysiological characterizations of DA’s actions have
been complicated by the fact that striatal interneurons also
express DA receptors, as do the synaptic terminals of striatal
afferents. In dorsal striatum, there are at least five distinct
subtypes of GABAergic interneurons (Tepper et al., 2010) and
one population of large aspiny cholinergic interneurons.
Although these interneurons collectively account for only 5%–
10% of all striatal neurons, they exert a powerful influence on
behavior (Gittis et al., 2011; Witten et al., 2010). Striatal
GABAergic interneurons can be distinguished based on the
expression of neuropeptides, synthetic enzymes, and calcium
binding proteins (e.g., parvalbumin [PV]-expressing fast-spiking
Table 2. Cellular Distribution of DA Receptors in the Cortex and Striatum of Rodents
D1 D2 D3 D4 D5
Striatum
dSPNs +++ (>90%)  + (50%) + (<10%) 
iSPNs + (<10%) +++ (>90%) + (<10%) + (<10%) + (<10%)
Cholinergic interneurons + (<20%) ++ (>80%)   ++ (>80%)
PV+ interneurons + (>70%)
NPY/SOM/NO+ interneurons + (<10%) + (>70%)
CR+ interneurons + (50%)
Cortex
L2/3 pyramidal neurons ++ (<20%) + (<10%) + +
L5/6 pyramidal neurons ++ (20%–40%) + (25%) + +
L2–L6 interneurons ++ (30%–60%)* + (20%)* + + +
This table reports semiquantitative expression levels of various DA receptor subtypes (+++, highest expression; +, low expression; , mRNA not de-
tected) and their relative cellular distribution (in parentheses) within defined cortical and striatal neuronal populations.
*For the most part, PV+ interneurons.
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nitric oxide synthase [NOS]-coexpressing low-threshold spiking
[LTS] interneurons, NPY only expressing neurogliaform, TH-
expressing interneurons, and calretinin [CR]-expressing inter-
neurons). Cholinergic interneurons mainly coexpress D2 and
D5 receptors, whereas PV+, CR+, and NPY/SOM/NOS+ inter-
neurons express D5 receptors (Rivera et al., 2002; Yan and
Surmeier, 1997). It is currently unknown whether NPY-neuroglia-
form and TH+ interneurons express DA receptors. In addition, D2
receptors adorn the presynaptic terminals of DA afferents (Ses-
ack et al., 1994), glutamatergic cortical and thalamic afferents
that innervate SPNs and interneurons (Wang and Pickel, 2002),
as well as GABAergic pallidostriatal neurons (Hoover and
Marshall, 2004), which mostly terminate on PV+ interneurons
and SPNs (Mallet et al., 2012). D1 receptors have also been
observed in a small number of presynaptic glutamatergic termi-
nals in striatum (Dumartin et al., 2007). Lastly, SPNs provide
lateral inhibition onto each other through recurrent axon collat-
erals that contain D1 or D2 receptors, depending on SPN
subtype (Guzma´n et al., 2003; Taverna et al., 2005; Tecuapetla
et al., 2009). Thus, DA probably initiates a complex cascade of
modulatory events in striatum that has the potential to vary
dynamically depending on the recruitment of distinct striatal
circuits.
In cerebral cortex, the cellular distribution of DA receptors
is not as well delineated. The distribution and density of meso-
cortical DA fibers and cortical DA receptors varies between
species, as well as between and within cortical areas in a given
species (Bentivoglio and Morelli, 2005), limiting the ability to
extract general DA signaling principles. Most studies have
focused on PFC, which is the principal cortical recipient of DA
afferents. During the past two decades, a large number of histo-
logical studies have confirmed that D1 receptors are the most
widespread and strongly expressed DA receptors in PFC. D1
and D2 receptors distribute to both pyramidal neurons and
interneurons throughout layers (L) 2 to 6, but most prominently
in deep cortical layers (Bentivoglio and Morelli, 2005; Santana
et al., 2009), where DA innervation is densest. In PFC pyramidalneurons, D1 receptor mRNA is expressed in approximately
20% of layer L2/3 and L5 and in 40% of L6 pyramidal cells (Table
2). By contrast, D2 receptor mRNA is only sparsely detected
in superficial layer pyramidal neurons (5% in L2/3) and in 25%
and 13% of L5 and L6 pyramidal cells, respectively (Santana
et al., 2009). The cellular distribution of D5 receptors in pyramidal
neurons overlaps with that of D1 receptors (Bergson et al., 1995),
and D3 and D4 receptors mostly distribute to GABAergic inter-
neurons (Khan et al., 1998). Therefore, unlike striatum, DA recep-
tors in PFC may only be expressed in a fraction of projection
neurons, indicating that a considerable number of pyramidal
cells may not be subject to direct modulation by DA. Moreover,
DA receptor expression in PFC pyramidal neurons does not
delineate a functionally homogeneous group of cells, as only
a small proportion of corticostriatal (6%–11%), corticothalamic
(25%), and corticocortical (4%–10%) neurons expressed D1
or D2 receptors (Gaspar et al., 1995).
Although the total number of DA receptor-expressing pyra-
midal neurons exceeds that of interneurons, DA receptors
are proportionally more widespread and homogeneously ex-
pressed within local interneuron populations. D1 receptor
mRNA is present in 30%–60% of all GABA-containing cortical
interneurons across cortical layers in rat (Le Moine and Gaspar,
1998; Santana et al., 2009). The vast majority of these cells are
PV+ FS interneurons and calbindin (CB)-expressing LTS inter-
neurons but only rarely CR+ interneurons; it is estimated that
up to 60% of PV+, 25% of CB+, and <10% of CR+ interneurons
express D1 receptors (Le Moine and Gaspar, 1998). The fraction
of interneurons expressing D1-like receptors may be larger, as
D5 receptors complement the expression pattern of D1 recep-
tors, labeling mostly CR+ interneurons, and less so PV+ inter-
neurons (Glausier et al., 2009). By contrast, D2 receptors
distribute to a comparatively smaller fraction of cortical
GABAergic interneurons: only 5%–17% of interneurons contain
D2 receptor mRNA (Santana et al., 2009), the majority of which
consist of PV+ interneurons (Le Moine and Gaspar, 1998).
Although D3 and D4 receptors may complement the expression
of D2 receptors in cortical interneurons, their overall distributionNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 37
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Figure 3. DA Modulation of Neurotransmitter Release
Summary of modulatory effects of DA on transmitter release (small circled
arrows) in striatum (A) and cortex (B). Principal cells are depicted in blue and
interneurons in green. Glutamatergic, GABAergic, and cholinergic synaptic
inputs are represented as triangles, circles, and squares shaded to reflect
modulation by D1-class (black) or D2-class (white) receptors. Lack of
presynaptic modulation by DA is shown in gray. The identity of the presynaptic
cell (inferred or deducted from paired recordings) is indicated where possible.
Note that some modulatory changes only apply to striatal subdivisions (dorsal
versus ventral) and that inconsistencies exist (e.g., DA modulation of
GABAergic inputs onto L5 PCs). CIN, cholinergic interneuron; PC, pyramidal
cell.
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are unlikely to distribute to a large proportion of GABAergic
interneurons.
Transgenic mice have the potential to help identify cortical
cells with transcriptionally active DA receptor genes. However,
currently available transgenic lines for D1 and D2 receptors
were selected based on the fidelity of transgene expression in
striatal neurons (Valjent et al., 2009). Comparatively little is
known in cortex regarding the penetrance and specificity of
these transgenes in D1 and D2 receptor-expressing neurons. A
recent study by Zhang et al. (2010) determined that Drd2-
EGFP/Drd1a-tdTomato BAC transgenic mice express EGFP in
over 90% of PFC pyramidal neurons and tdTomato in 16%–
25% of pyramidal cells, most of which coexpress EGFP, without
any region or layer-specific differences. This distribution stands
in stark contrast to that described previously (Bentivoglio and
Morelli, 2005). In another recent study (Gee et al., 2012), PFC
pyramidal neurons identified in Drd2-EGFP and Drd2-Cre BAC
transgenic mice were found to project to thalamus but not
contralateral cortex, unlike previous descriptions using in situ38 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.hybridization (Gaspar et al., 1995). These discrepancies
probably speak to the weaknesses of both histological and
transgenic approaches. BAC transgenes are generated by
nonspecific integration into the target genome and are not
immune to positional effects, requiring phenotypic characteri-
zation of several transgenic lines before identifying the ones
that most closely recapitulate endogenous gene expression
patterns. Moreover, transgenic reporter and effector proteins
are not subject to the same posttranscriptional and homeostatic
regulatory mechanisms that control GPCR expression and
may therefore highlight cells that do not functionally detect DA
under normal conditions. Conversely, low-abundance GPCR
transcripts may be functionally relevant but below the detection
limit of conventional histological methods. Therefore, more
functional studies like the one recently performed on L5 PFC
pyramidal neurons in Drd1a-TdTomato mice (Seong and Carter,
2012) are needed to determine whether BAC transgene expres-
sion in brain areas other than striatum accurately identifies
neurons that are directly modulated by DA.
DA Modulation of Neurotransmitter Release
One of the many ways neuromodulators influence synaptic
transmission is by regulating release of neurotransmitters. Neu-
romodulators can initiate changes in release probability (Prelease)
either by activating presynaptic receptors or by eliciting the liber-
ation of retrograde signaling molecules from the postsynaptic
membrane. Thus, modulation of Prelease by DA cannot simply
be inferred based on presynaptic localization of DA receptors,
nor can it be excluded in their absence. For the purposes of this
Review, we focus on electrophysiological studies in acute brain
slices that clearly identify a presynaptic modulatory effect of DA
either through analysis of tetrodotoxin (TTX)-resistant ‘‘minia-
ture’’ excitatory or inhibitory postsynaptic currents (mEPSCs or
mIPSCs), paired-pulse ratios, or evoked excitatory or inhibitory
postsynaptic currents (EPSCs or IPSCs) when postsynaptic
changes in neurotransmitter receptor composition have been
excluded.
DA acting through both D1 and D2 receptor families has been
implicated in heterosynaptic regulation of Prelease at glutamater-
gic, GABAergic, and cholinergic terminals (Figure 3). Specifi-
cally, D2-like receptor activation decreases release of glutamate
onto SPNs in dorsal and ventral striatum (Bamford et al., 2004;
Higley and Sabatini, 2010; Salgado et al., 2005; Wang et al.,
2012). D2-like receptors also decrease Prelease of GABA onto
PFC pyramidal neurons (Chiu et al., 2010; Seamans et al.,
2001b; Xu and Yao, 2010), SPNs (Delgado et al., 2000; Guzma´n
et al., 2003; Kohnomi et al., 2012; Taverna et al., 2005; Tecua-
petla et al., 2009), and striatal interneurons (Bracci et al., 2002;
Centonze et al., 2003; Momiyama and Koga, 2001; Pisani
et al., 2000). In addition, D2-like receptors depress release of
acetylcholine (Ach) onto striatal cholinergic interneurons (Pisani
et al., 2000). D1-like receptor stimulation decreases release of
glutamate onto L5 pyramidal cells in PFC (Gao et al., 2001;
Gao and Goldman-Rakic, 2003; Gonzalez-Islas and Hablitz,
2003; Seamans et al., 2001a) and SPNs in ventral striatum
(Harvey and Lacey, 1997; Nicola and Malenka, 1997; Pennartz
et al., 1992; Wang et al., 2012) but not dorsal striatum (Nicola
and Malenka, 1998). Moreover, DA-mediated activation of
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neurons (Towers and Hestrin, 2008), L2–L5 PFC pyramidal
neurons (Gao et al., 2003; Gonzalez-Islas and Hablitz, 2001),
and SPNs in ventral striatum only (Nicola and Malenka, 1997,
1998; Pennartz et al., 1992; Taverna et al., 2005). Thus, at
synapses responsive to DA modulation, DA typically acts to
decrease Prelease.
There are, however, some notable exceptions to this simple
view. DA and D1-like receptor agonists enhance GABA release
from dSPN axon collaterals (Guzma´n et al., 2003). Such D1-
like receptor-induced facilitation of transmitter release is con-
sistent with the previously reported presynaptic enhancement
of neurotransmission by cAMP and PKA at hippocampal and
cerebellar synapses (Chen and Regehr, 1997; Trudeau et al.,
1996). In addition, the D2-like receptor agonist quinpirole was
reported to increase GABA release in a third of synaptic connec-
tions formed by FS interneurons onto SPNs in nucleus accum-
bens and to decrease it in another third (Kohnomi et al., 2012).
The variable or inconsistent nature of some of these observa-
tions may arise from cell type or synaptic heterogeneity or from
the recruitment of other neuromodulatory systems that in turn
influence release probability. In cortex, DA differentially influ-
ences GABAergic transmission from FS and non-FS inter-
neurons onto pyramidal neurons: it depresses GABA release
from FS interneurons and potentiates inhibitory postsynaptic
potentials initiated by non-FS cells without affecting electro-
physiological measures of Prelease (Gao et al., 2003). In striatum,
anatomical studies indicate that presynaptic D1 and D2 recep-
tors are only expressed in a small fraction of glutamatergic
synapses (Dumartin et al., 2007; Wang and Pickel, 2002), in
agreement with reports of sparse DA receptor expression in
a subset of striatum-projecting L5 pyramidal neurons (Gaspar
et al., 1995). This observation is corroborated by functional
imaging studies of vesicular release from corticostriatal affer-
ents, in which DA modulation is limited to only a small number
of terminals (Bamford et al., 2004; Wang et al., 2012). Moreover,
DA modulates the activity of cholinergic interneurons (Aosaki
et al., 1998; Pisani et al., 2000) and can promote the postsynaptic
liberation of adenosine and endocannabinoids from SPNs,
which independently influence transmitter exocytosis through
the activation of presynaptic GPCRs (Harvey and Lacey, 1997;
Oldenburg and Ding, 2011; Wang et al., 2012).
Molecular Substrates of Presynaptic DA Modulation
The molecular mechanisms of DA’s action on presynaptic
terminals remain poorly understood due to technical difficulties
associated with probing presynaptic intracellular signal
cascades. D1- and D2-like receptor agonists inhibit somatic
CaV2.1 (P/Q-type) and CaV2.2 channels (Salgado et al., 2005;
Surmeier et al., 1995; Yan et al., 1997), which are primarily
responsible for initiating neurotransmission in the CNS. These
Ca2+ channels therefore constitute a likely substrate for the
presynaptic modulatory effect of DA. Indeed, inhibition of
CaV2.2 underlies the D2 receptor-induced reduction of GABA
release onto striatal cholinergic interneurons (Momiyama and
Koga, 2001; Pisani et al., 2000), and the D2 receptor-evoked
depression of GABA release from SPN axon collaterals depends
on modulation of CaV2.1 or CaV2.2 depending on age (Salgado
et al., 2005). However, DA’s effects on neurotransmitter releaseare not exclusively mediated through presynaptic modulation
of Ca2+ channels; in ventral striatum, DA acting on D1-like
receptors depresses excitatory transmission independently of
presynaptic Ca2+ influx (Nicola and Malenka, 1997).
Pre- and Postsynaptic Regulation of Transmitter
Release by DA
While there are good reasons to believe that DA modulates
transmitter release by directly activating presynaptic DA recep-
tors, experimental evidence formally excluding the involvement
of postsynaptic receptors is rare, especially at synapses in which
DA receptors are expressed both pre- and postsynaptically.
Using paired recordings from synaptically connected SPNs,
Tecuapetla et al. (2009) showed that DA acting on D2 but not
D1 receptors depresses GABA release from iSPNs (expressing
D2 receptors) onto dSPNs (expressing D1 receptors), providing
compelling evidence for a direct presynaptic locus of action. In
striatum, activation of D2 receptors diminishes presynaptic
release of glutamate from corticostriatal afferents (Bamford
et al., 2004; Higley and Sabatini, 2010; Salgado et al., 2005;
Wang et al., 2012). Although commonly attributed to activation
of presynaptic D2 receptors, DA and D2 receptor agonists
have small (Wang et al., 2012) or negligible effects on mEPSCs
(Andre´ et al., 2010; Nicola and Malenka, 1998), the reduction in
evoked glutamate release scales with afferent stimulation
frequency (Bamford et al., 2004; Yin and Lovinger, 2006) and is
prevented by postsynaptic Ca2+ buffering as well as pharmaco-
logical and genetic blockade of metabotropic glutamate and
endocannabinoid receptors (Tozzi et al., 2011; Wang et al.,
2012; Yin and Lovinger, 2006). While these studies do not
exclude a role for presynaptic D2 receptors, they suggest that
under conditions of elevated synaptic activity, DA and glutamate
interact postsynaptically to decrease synaptic drive through the
synthesis of endocannabinoid retrograde messengers. A similar
inhibitory feedback pathway relying on postsynaptic release of
adenosine has been proposed downstream of D1-like and
NMDA receptors in ventral striatum (Harvey and Lacey, 1997;
Wang et al., 2012), though this has not been universally observed
(Nicola and Malenka, 1997).
Using optical imaging of exocytic events and electrophysio-
logical recordings from EGFP-labeled dSPNs and iSPNs in
BAC transgenic mice, Wang et al. (2012) recently dissected the
presumed pre- and postsynaptic effects of D1 and D2 receptors
on glutamate release from corticoaccumbal afferents. Under
conditions of minimal synaptic activity (i.e., in TTX), their studies
revealed slight presynaptic excitatory and inhibitory effects of
D1- and D2-like receptor agonists on glutamate release, respec-
tively. Under conditions of moderate to high corticoaccumbal
activity (spontaneous and evoked EPSCs), stimulation of D1-
and D2-like receptors both evoked a more pronounced
decrease in glutamate release that originated postsynaptically
and occluded presynaptic contributions. The D1 receptor-
mediated downregulation of glutamate release required AMPA
and NMDA receptors and resulted from activation of presynaptic
adenosine A1 receptors after postsynaptic liberation of adeno-
sine. By contrast, D2 receptors interacted postsynaptically
with metabotropic glutamate receptors to stimulate endocanna-
binoid production. This same pathway is known to be required
for long-term depression of glutamate release onto iSPNs inNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 39
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DA on transmitter release are therefore complex, context-
dependent, and not limited to the action of presynaptically
localized DA receptors. The observation that other neuromodu-
latory systems can independently be engaged by DA further
complicates analyses of the mechanisms employed by endoge-
nous DA to modulate transmitter release.
DA Modulation of Postsynaptic Neurotransmitter
Receptors
Postsynaptic neurotransmitter receptors are likely targets for the
neuromodulatory effects of DA. During the past two decades,
in vitro studies demonstrating rapid DA receptor-mediated
modulation of ionotropic glutamate and GABA receptor function
and trafficking have abounded, leaving little doubt as to the
ability of DA to regulate them. However, the nature and conse-
quences of these interactions are complex and controversial,
owing to differences in DA’s actions across brain areas, cell
types, and experimental conditions.
DA Modulation of NMDA Receptors
It is generally accepted that DA acting on D1-like receptors
potentiates currents, membrane depolarization, and cytosolic
Ca2+ levels evoked by ionotophoretic or bath application of
NMDA receptor agonists in acutely dissociated neurons (Andre´
et al., 2010; Chen et al., 2004; Flores-Herna´ndez et al., 2002;
Jocoy et al., 2011) or slice preparations from PFC and striatum
(Cepeda et al., 1998; Levine et al., 1996a; Tseng and O’Donnell,
2004; Zheng et al., 1999). Neuronal glutamate receptors
distribute to both synaptic and nonsynaptic membranes, but
the receptors that populate these membrane domains are
distinct with respect to subunit composition, trafficking regula-
tory mechanisms and function (Gladding and Raymond, 2011;
Shepherd and Huganir, 2007). By virtue of the fact that exoge-
nous application of agonists preferentially targets somatic and
extrasynaptic receptors, these studies collectively indicate that
D1 receptor stimulation can potentiate extrasynaptic NMDA
receptor function. Several mechanisms have been proposed
to underlie this potentiation, most of which implicate NMDA
receptor phosphorylation and membrane trafficking, although
the intracellular effectors involved are a matter of debate
(Braithwaite et al., 2006; Flores-Herna´ndez et al., 2002; Gao
and Wolf, 2008; Hallett et al., 2006). Importantly, many of the
studies reporting enhancements of NMDA receptor function
in slices either measured membrane potential or recorded
membrane currents under conditions that do not minimize errors
associated with the inability to adequately voltage clamp distal
dendrites. This is particularly problematic when investigating
functional contributions of NMDA receptors, for which gating
is voltage dependent. Indeed, DA modulation of dendritic
voltage-gated Ca2+ channels has been shown to contribute
indirectly to NMDA receptor potentiation, possibly by helping
relieve Mg2+ block (Cepeda et al., 1998).
It has been comparatively more difficult to establish whether
D1 receptors also affect synaptically localized NMDA receptors,
as synaptic stimulation experiments require conditions that
additionally exclude contributions from DA’s actions on local
interneurons and presynaptic release. Nevertheless, activation
of D1-like receptors potentiates miniature and electrically40 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.evoked NMDA receptor EPSCs through postsynaptic signaling
involving PKA and protein kinase C (PKC) in PFC (Gonzalez-Islas
and Hablitz, 2003; Li et al., 2010; Seamans et al., 2001a). In
striatum, synaptically evoked NMDA receptor EPSCs are
potentiated by D1-like receptor stimulation in some studies
(Jocoy et al., 2011; Levine et al., 1996b) but remain unaffected
by DA in others (Beurrier and Malenka, 2002; Nicola and Mal-
enka, 1998).
Several studies have also presented evidence that currents
evoked by exogenous NMDA application can be attenuated by
stimulation of D1-like (Castro et al., 1999; Lee et al., 2002; Lin
et al., 2003; Tong and Gibb, 2008) or D2-like (Andre´ et al.,
2010; Flores-Herna´ndez et al., 2002; Jocoy et al., 2011; Kotecha
et al., 2002; Li et al., 2009; Liu et al., 2006; Wang et al., 2003;
Zheng et al., 1999) receptors. One concern associated with
some electrophysiological experiments showing depressing
effects of D1-like receptor agonists is that they may have been
confounded by direct, nonspecific effects of these agents on
NMDA receptors; high concentrations of DA or SKF38393,
a D1-like receptor agonist, promote rapid, reversible, and
voltage-dependent blockade of NMDA receptor currents in
cultured hippocampal, striatal, and thalamic neurons (Castro
et al., 1999; Kotecha et al., 2002). With few exceptions (Wang
et al., 2003), most reports of decreased NMDA receptor function
by DA point to mechanisms independent of G protein signaling,
resulting either from direct protein-protein interactions between
NMDA receptors and D1 and D2 receptors (Lee et al., 2002; Liu
et al., 2006) or from the activation of intracellular tyrosine kinases
(Kotecha et al., 2002; Li et al., 2009; Tong and Gibb, 2008).
However, few studies have revealed diminished function of
synaptic NMDA receptors after DA application. In striatum, post-
synaptic NMDA receptor currents evoked by electrical stimu-
lation or two-photon glutamate uncaging are unperturbed by
D2 receptor agonists (Higley and Sabatini, 2010; Levine et al.,
1996b). Interestingly, a PKA-dependent decrease in Ca2+ influx
through NMDA receptors was observed in iSPNs upon D2
receptor activation, indicating that while D2 receptors do not
directly modulate the depolarizing currents contributed by
NMDA receptors, they can limit the activation of Ca2+-dependent
pathways downstream of NMDA receptors (Higley and Sabatini,
2010), an effect likely due to the regulation of NMDA receptor
Ca2+ permeability by PKA phosphorylation of the channel
(Chalifoux and Carter, 2010; Skeberdis et al., 2006). Likewise,
the D2-like receptor agonist quinpirole did not significantly
affect NMDA receptor EPSCs in L2/3 PFC pyramidal neurons
(Gonzalez-Islas and Hablitz, 2003). By contrast, selective phar-
macological activation of D4 receptors suppresses synaptically
evoked NMDA receptor EPSCs in cortex through PKA-depen-
dent NMDA receptor internalization (Wang et al., 2003). Thus,
DA has the capacity to bidirectionally modulate synaptic
NMDA receptors through D1- and D2-class receptors, but the
susceptibility of individual synapses across brain areas and the
intracellular pathways recruited vary greatly.
DA Modulation of AMPA Receptors
As for NMDA receptors, there is a large body of evidence
showing that DA bidirectionally modulates the function and
membrane trafficking of AMPA receptors. Biochemical studies
have demonstrated that D1 receptor agonists and D2 receptor
Neuron
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receptors, whereas D2 receptor agonists diminish it by favoring
PP1 activity (Ha˚kansson et al., 2006; Snyder et al., 2000). PKA
phosphorylation increases AMPA receptor peak open proba-
bility and extrasynaptic membrane expression (Shepherd and
Huganir, 2007). Consistent with this, D1 receptors acting through
PKA increase surface AMPA receptors in neuronal cultures
prepared from nucleus accumbens (Sun et al., 2008) and PFC
(Sun et al., 2005), whereas D2 receptor agonists decrease
surface AMPA receptor levels (Sun et al., 2005). Moreover,
membrane currents and potentials evoked by local application
of AMPA receptor agonists in striatal and cortical neurons are
depressed by D2 receptor stimulation (Andre´ et al., 2010; Her-
na´ndez-Echeagaray et al., 2004; Levine et al., 1996a) and are
either unaffected (Calabresi et al., 1995; Seamans et al.,
2001a; Zheng et al., 1999) or potentiated (Andre´ et al., 2010;
Levine et al., 1996a; Lin et al., 2003; Yan et al., 1999) by D1
receptor agonists. Importantly, DA receptor signaling is not
sufficient to recruit AMPA receptors to postsynaptic terminals
(Sun et al., 2005, 2008), probably because AMPA receptor
surface expression and synaptic targeting by lateral diffusion
constitute two independent and separately regulated trafficking
steps (Shepherd and Huganir, 2007). Thus, modifications of
AMPA receptor surface expression at extrasynaptic membranes
by DAmay not necessarily extend to synaptic sites. Indeed, very
few studies have reported increased or decreased postsynaptic
AMPA receptor currents in response stimulation of D1- or
D2-class receptors, respectively (Gonzalez-Islas and Hablitz,
2003; Levine et al., 1996b). In most cases, postsynaptic AMPA
receptor function was unaltered by DA or D1 receptor agonists
in PFC (Gao et al., 2001; Gao and Goldman-Rakic, 2003;
Seamans et al., 2001a; Zhou and Hablitz, 1999) and striatum
(Bracci et al., 2002; Levine et al., 1996b; Nicola and Malenka,
1997, 1998). Likewise, D2 receptor agonists do not significantly
alter synaptically evoked AMPA receptor EPSCs in cortex or
striatum using electrical stimulation (Gonzalez-Islas and Hablitz,
2003; Pisani et al., 2000), two-photon glutamate uncaging
(Higley and Sabatini, 2010), or paired recordings (Gao et al.,
2001). Together, these studies indicate that activation of DA
receptors is not sufficient to modify the number or conductance
of synaptic AMPA receptors. Instead, DA might need to work in
concert with other signaling molecules to promote synaptic
AMPA receptor incorporation.
DA Modulation of GABAA Receptors
Despite widespread reports of GABAA receptor phosphorylation
and current modulation by PKA and PKC (reviewed in Kittler and
Moss, 2003), comparatively few studies have observed DA
modulation of GABAA receptor function. In deep layer PFC
pyramidal neurons, DA reduces postsynaptic GABAA receptor
currents at synaptic and extrasynaptic sites through D4
receptor-mediated downregulation of surface receptors (Gra-
ziane et al., 2009; Seamans et al., 2001b; Wang et al., 2002). In
striatum, D1 and D5 receptors respectively decrease and
enhance GABAA receptor currents evoked by local application
of GABA on the somata of acutely dissociated SPNs (Flores-
Hernandez et al., 2000) and cholinergic interneurons (Yan and
Surmeier, 1997). Aside from these, most studies investigating
DA modulation of synaptic GABAergic transmission either failedto detect changes in postsynaptic inhibitory currents or poten-
tials or assigned them to presynaptic modifications in GABA
release or postsynaptic membrane properties in PFC (Gao
et al., 2003; Gonzalez-Islas and Hablitz, 2001; Gulledge and
Jaffe, 2001; Kro¨ner et al., 2007; Towers and Hestrin, 2008;
Zhou and Hablitz, 1999) and striatum (Bracci et al., 2002;
Centonze et al., 2003; Delgado et al., 2000; Kohnomi et al.,
2012; Nicola and Malenka, 1997, 1998; Pisani et al., 2000;
Taverna et al., 2005; Tecuapetla et al., 2009).
DA Modulation of Postsynaptic Excitability
and Synaptic Integration
Striatal Projection Neurons
During the past two and a half decades, evidence has accumu-
lated that DA exerts a powerful influence on SPN intrinsic excit-
ability. Early electrophysiological studies in slice indicated that
DA can both enhance and reduce SPN spiking evoked by intra-
cellular current injection (reviewed in Nicola et al., 2000). Not
surprisingly, the polarity and magnitude of these alterations
depended in large part on the type of DA receptor activated.
However, the picture that arose initially is opposite of the one
that constitutes our current understanding of DA’s effects on
intrinsic excitability. It was determined that activation of D1
receptors diminishes SPN excitability, whereas D2 receptor
signaling promotes excitation (Nicola et al., 2000). The advent
of improved methodologies to identify and record from dSPNs
and iSPNs in situ, combined with a greater understanding of
the contribution of individual ionic conductances to the overall
behavior of SPNs, have reversed this view to the one originally
advanced by anatomists and pathologists some 20 years ago,
namely that DA favors the activation of dSPNs and reduces the
excitability of iSPNs (Gerfen and Surmeier, 2011).
Under basal conditions, dSPNs and iSPNs exhibit small but
significant differences in dendritic morphology and membrane
properties that translate into greater excitability of iSPNs over
dSPNs. Although the cell types do not differ with regards to
input resistance and resting membrane potential, the action
potential discharge rate of iSPNs is twice that of dSPNs in
response to somatic current injection (Gertler et al., 2008; Kreit-
zer and Malenka, 2007). Morphologically, the dendrites of
dSPNs and iSPNs are studded with a similarly high density of
spines, but iSPNs possess more primary dendrites compared
to dSPNs, resulting in a functionally greater number of excitatory
synaptic contacts onto these cells (Day et al., 2006; Gertler et al.,
2008; Kreitzer and Malenka, 2007). The dendrites of iSPNs are
also more excitable than those of dSPNs (Day et al., 2008). While
some of the differential effects of DA on SPN excitability admit-
tedly originate from circuit-level interactions between striatal
cells, DA directly influences SPN excitability by modulating ion
channels, several of which have been defined. Modulation of
any of these channels has the potential to significantly alter
SPN excitability, although the relative impact of these changes
critically depends on membrane potential, as the array of
voltage-gated ion channels engaged at different potentials
varies considerably.
DA does not significantly alter SPN excitability by modulating
leak conductances as DA receptor agonists exert little or
no influence on SPN resting membrane potential or inputNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 41
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excitability and synaptic integration involve PKA-dependent
modulation of voltage-gated K+, Na+, and Ca2+ channels. In
both dorsal and ventral striatum, studies of pharmacologically
isolated currents have revealed that D1 receptors facilitate
inward rectifier K+ channels belonging to the Kir2 family
(Pacheco-Cano et al., 1996; Uchimura and North, 1990) and
decrease slowly inactivating A-type K+ currents attributed to
KV4 channels (Kitai and Surmeier, 1993). These changes are
predicted to impede synaptically driven transitions from the
hyperpolarized resting potential (so-called down state) to a
more depolarized, sustained potential near spike threshold (up
state), while enhancing action potential firing during up states
(Wickens and Arbuthnott, 2005). In addition, D1 receptor stimu-
lation increases CaV1 currents (Herna´ndez-Lo´pez et al., 1997;
Song and Surmeier, 1996; Surmeier et al., 1995), which poten-
tiate up state transitions, excitatory synaptic potentials, and
action potential discharge (Plotkin et al., 2011; Vergara et al.,
2003), and suppresses currents carried by CaV2.1 and CaV2.2
(Surmeier et al., 1995; Zhang et al., 2002), which limit repetitive
action potential firing by activating small (SK)- and large (BK)-
conductance Ca2+-dependent K+ channels (Hopf et al., 2010;
Vilchis et al., 2000). Interestingly, activation of D1 receptors
was recently shown to prolong ‘‘up state-like’’ potentials evoked
by repetitive glutamate uncaging on distal SPN dendrites (Plot-
kin et al., 2011). Generation of these regenerative plateau
potentials required NMDA receptors and low-threshold CaV3
channels, which are enriched in distal dendrites and spines
(Carter and Sabatini, 2004; Carter et al., 2007; Day et al.,
2006), but it is currently unclear whether the D1 receptor-
evoked enhancement is mediated by direct modulation of
NMDA receptors or dendritic K+ and Ca2+ conductances or
both. Thus, through its actions on voltage-gated K+ and Ca2+
channels, D1 receptors promote synaptic integration and spike
discharge during up states while increasing the threshold for
upward transitions, effectively acting to enhance contrast
between up and down states. However, this relatively simple
and consistent view of DA’s action on dSPNs is complicated
by the reported effects on voltage-gated Na+ currents, which
are reduced in amplitude by DA and D1-like receptor agonists
(Cepeda et al., 1995; Schiffmann et al., 1995; Surmeier et al.,
1992; Zhang et al., 1998). This observation is largely responsible
for the initial conclusion that D1 receptors exert a net inhibitory
action on SPN excitability (Nicola et al., 2000). The apparently
conflicting actions of DA on various ionic conductances reflect
some of the difficulties associated with extrapolating overall
neuromodulatory effects of DA from changes in isolated con-
ductances. Given the importance of subthreshold membrane
potential fluctuations to SPN function and the inability of
somatic current injection protocols to engage distal dendritic
conductances (Day et al., 2008) and to evoke state transitions
in acute slices (Wilson, 2004), analyses of spike discharge
modulation upon somatic depolarization may not adequately
capture DA’s influence on synaptic integration and intrinsic
excitability. Nevertheless, although the spike-promoting effects
of D1 receptors on K+ and Ca2+ channels may be moderated by
reduced Na+ channel availability, most of the evidence accrued
to date favors models in which D1 receptors promote dSPN42 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.intrinsic excitability (Gerfen and Surmeier, 2011; Wickens and
Arbuthnott, 2005).
The reported effects of D2 receptor activation on isolated ionic
conductances and up state potentials in SPNs largely oppose
those of D1 receptors. Through their inhibitory action on PKA,
D2 receptors suppress currents attributable to Kir2 channels
but enhance depolarization-activated and ATP-sensitive K+
channels (Greif et al., 1995; Perez et al., 2006; Sun et al., 2000;
Surmeier and Kitai, 1993), indicating that D2 receptor activation
may facilitate up state transitions but stunt their duration and
the depolarization achieved. D2 receptors further limit somatic
excitability by decreasing Ca2+ influx through somatic CaV1
channels (Hernandez-Lopez et al., 2000; Salgado et al., 2005).
In dendritic shafts and spines, D2 receptor stimulation mainly
decreases Ca2+ currents carried by CaV2.3, which gate dendritic
SK channels (Higley and Sabatini, 2010), although synaptic
potentials evoked by glutamate uncaging remain unaffected by
quinpirole (Higley and Sabatini, 2010), perhaps due to concur-
rent potentiation of dendritic Kv4 channels (Day et al., 2008).
Moreover, D2 receptors shorten regenerative plateau potentials
evoked by glutamate uncaging on the distal dendrites of iSPNs
(Plotkin et al., 2011), possibly by decreasing Ca2+ influx through
NMDA receptors or voltage-gated Ca2+ channels (Day et al.,
2008; Higley and Sabatini, 2010). Unlike D1 receptors, the
effects of D2 receptors on Na+ channels are inconsistent: they
were found to enhance, suppress, or have no effects in subpop-
ulations of SPNs in ventral and dorsal striatum (Hu et al., 2005;
Surmeier et al., 1992; Zhang et al., 1998). Together, this body
of work depicts a relatively coherent model of modulation by
D2 receptors, in which DA suppresses iSPN synaptic integration
and spiking output by diminishing the potential and duration
of up states and by limiting the spread and depolarization of
synaptic potentials.
Striatal Interneurons
Among the six populations of striatal interneurons characterized
to date, the modulatory actions of DA have been investigated
only in cholinergic, FS, and LTS interneurons. The latter pos-
sess wide axonal arbors that innervate a large number of
SPNs, and DA depolarizes these cells by activating D5 receptors
(Centonze et al., 2002; Tepper et al., 2010). FS interneurons inte-
grate glutamatergic inputs from cortex and establish strong
GABAergic synapses on the somata of surrounding SPNs, form-
ing a potent feedforward inhibitory circuit that preferentially
targets dSPNs over iSPNs (Tepper et al., 2010). FS interneurons
also receive a GABAergic projection from GPe (Mallet et al.,
2012). Studies in striatal slices have revealed that DA directly
and dose dependently depolarizes the membrane of FS inter-
neurons via D5 receptors, possibly by promoting the closure of
a K+ conductance (Bracci et al., 2002; Centonze et al., 2003).
In combination with the D2 receptor-mediated selective
decrease of GABAergic (but not glutamatergic) inputs onto these
cells, DA is believed to limit the influence of GPe afferents and
local interneurons, while promoting corticostriatal feedforward
inhibition of SPNs.
The DA and cholinergic systems dynamically and reciprocally
influence each other in numerous ways, many of which continue
to be unraveled (Cragg, 2006; Threlfell et al., 2012). Cholinergic
interneurons are tonically active in vivo and respond to
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be preceded or followed by a transient increase in firing (Cragg,
2006). Experiments in vivo have suggested that this pause is
dependent on DA (Aosaki et al., 1994), and several in vitro
studies have since revealed potential cellular and molecular
substrates for this interaction (reviewed in Goldberg and Rey-
nolds, 2011). Cholinergic interneurons express D2 and D5 re-
ceptors (Rivera et al., 2002; Yan and Surmeier, 1997) and
pharmacological studies have reported both excitatory and
inhibitory modulatory changes by DA. In slice, DA and D5 re-
ceptor stimulation depolarize cholinergic interneurons and pro-
mote spiking through cAMP-dependent suppression of a K+
conductance and opening of an undefined cation channel
(Aosaki et al., 1998; Centonze et al., 2003; Pisani et al., 2000).
By contrast, application of DA together with a D1-like receptor
antagonist reveals a hyperpolarizing current (Aosaki et al.,
1998), indicating that D5 and D2 receptors both influence the
membrane potential of cholinergic interneurons. In agreement
with this, direct activation of D2 receptors evokes a dose-depen-
dent depolarization and action potential firing (Maurice et al.,
2004; Tozzi et al., 2011; but see Pisani et al., 2000, 2006). The
effect of D2 receptors has been proposed to be mediated by
reductions in a persistent Na+ current and a hyperpolarization-
activated, cyclic-nucleotide-gated (HCN) cation current that
controls pacemaking (Deng et al., 2007; Maurice et al., 2004).
In addition, D2 receptor stimulation reduces CaV2.2 currents in
dissociated cholinergic interneurons (Pisani et al., 2006; Yan
et al., 1997) and in striatal slices (Ding et al., 2006), which may
underlie the D2 receptor-mediated depression of presynaptic
Ach release (Pisani et al., 2000). Because CaV2.2 channels are
functionally coupled to somatodendritic SK channels, which
contribute to spike afterhyperpolarizing potentials (Goldberg
and Wilson, 2005), downregulation of CaV2.2 by D2 receptors
is expected to disrupt autonomous pacemaking and promote
a transition to burst firing (Goldberg and Wilson, 2005). Endoge-
nous activation of D5 receptors using electrical stimulation
quickly and transiently prolongs interspike intervals by augment-
ing spike afterhyperpolarization (Bennett and Wilson, 1998),
which stands in contrast to the increase in firing observed with
bath application of DA or D1-like receptor agonists (Aosaki
et al., 1998). Thus, although the net effect of DA on the intrinsic
excitability of cholinergic interneurons appears to be excitatory
(Aosaki et al., 1998; Centonze et al., 2003; Pisani et al., 2000),
signaling through D2 and D5 receptors exert opposite effects
and the specific conductances that underlie DA’s actions remain
to be defined. Given that DA presynaptically inhibits GABAergic
but not glutamatergic inputs onto cholinergic interneurons (Mo-
miyama and Koga, 2001; Pisani et al., 2000) and that excitatory
inputs precisely regulate spike timing in these cells (Bennett and
Wilson, 1998), DA may promote the synchronous activation
of cholinergic interneurons, engendering a complex cascade of
signaling events resulting in further DA release and inhibition of
SPN output (English et al., 2012; Threlfell et al., 2012; Witten
et al., 2010).
Prefrontal Cortex Pyramidal Neurons
The prefrontal cortex is the major cortical recipient of DA inputs
and DA is believed to play a critical role in several cognitive
processes conducted by PFC networks, including workingmemory, attention, and decision making. Although considerable
efforts have been invested during the past several decades in
elucidating the cellular mechanisms by which DA modulates
PFC function, the actions of DA and the underlying receptors
and signaling pathways involved remain controversial. What is
clear is that DA modulates the intrinsic excitability of both pyra-
midal neurons and local interneurons and that DA’s actions on
the latter has historically confounded in vivo and in vitro investi-
gations of its effects on the former (reviewed in Seamans and
Yang, 2004). In addition, PFC is composed of several functionally
distinct pyramidal and nonpyramidal cell types that receive
variable dopaminergic innervation along their dendritic trees
and express different levels and combinations of DA receptors
across cortical layers (Wang et al., 2006). Finally, the functional
implications of modulatory effects on isolated currents are often
unclear due to the large number of ionic conductances that
shape synaptic potentials and spike output, the dependence of
these processes on membrane potential, and the complexity of
the network in which these cells are embedded.
In the majority of in vitro studies in which synaptic contribu-
tions are pharmacologically excluded, DA enhances the intrinsic
excitability of deep layer PFC pyramidal neurons by elevating the
resting membrane potential or promoting a slow but long-lasting
increase in the number of action potentials evoked by somatic
depolarization (Ceci et al., 1999; Gao and Goldman-Rakic,
2003; Gulledge and Jaffe, 2001; Gulledge and Stuart, 2003; Kro-
ener et al., 2009; Lavin and Grace, 2001; Moore et al., 2011;
Penit-Soria et al., 1987; Shi et al., 1997; Wang and Goldman-
Rakic, 2004; Yang and Seamans, 1996). In most cases, DA’s
actions are selectively abolished by D1-like receptor antagonists
and mimicked by D1-like agonists (Chen et al., 2007; Gao and
Goldman-Rakic, 2003; Gulledge and Jaffe, 2001; Gulledge and
Stuart, 2003; Kroener et al., 2009; Lavin and Grace, 2001;
Penit-Soria et al., 1987; Seong and Carter, 2012; Shi et al.,
1997; Tseng and O’Donnell, 2004; Witkowski et al., 2008; Yang
and Seamans, 1996), implicating signaling through D1-class
receptors. Moreover, some studies have indicated that D2-like
receptors actively oppose D1 receptor-mediated excitation by
directly suppressing intrinsic neuronal excitability (Gulledge
and Jaffe, 1998; Tseng and O’Donnell, 2004). However, several
other studies have assigned DA-induced increased excitability
to D2-class receptors in deep layer pyramidal neurons (Ceci
et al., 1999; Gee et al., 2012; Moore et al., 2011; Wang and Gold-
man-Rakic, 2004) and have reported a net inhibitory effect of
D1-class receptors on spike output (Moore et al., 2011; Rotaru
et al., 2007). In L2/3 PFC pyramidal neurons, DA was shown to
promote (Henze et al., 2000) or leave unaffected action potential
firing evoked by somatic current injection (Gonzalez-Islas and
Hablitz, 2001; Zhou and Hablitz, 1999).
Regulation of several voltage-gated conductances may con-
tribute to these diverse effects. In PFC pyramidal neurons,
activation of D1 receptors reduces K+ currents carried by
inward-rectifying (Dong et al., 2004; Witkowski et al., 2008) and
voltage-activated (Dong and White, 2003; Dong et al., 2004,
2005; Yang and Seamans, 1996) K+ channels, which are respec-
tively expected to facilitate transitions to up states and help
sustain them once achieved. D1 receptor activation has been
shown to increase (Gorelova and Yang, 2000; Yang andNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 43
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Gulledge and Jaffe, 2001; Rotaru et al., 2007), or exert no effect
(Maurice et al., 2001) on the amplitude of persistent voltage-
activated Na+ currents. This diversity may result in part from
the voltage dependence of this modulation (Gorelova and
Yang, 2000). In addition, D1 receptor agonists inhibit transient
voltage-sensitive Na+ currents (Maurice et al., 2001; Peterson
et al., 2006; but see Gulledge and Jaffe, 2001; Gulledge and
Stuart, 2003). Some of these effects are consistent with the
differential modulation of transient and persistent Na+ currents
by PKA and PKC (Chen et al., 2006; Franceschetti et al., 2000),
which are both engaged by D1-like receptors in PFC neurons
and together exert a net positive influence on membrane excit-
ability (Franceschetti et al., 2000). Modulation of Na+ channels
can not only influence action potential initiation and discharge
rate, but also the amplitude of synaptic potentials and their
active propagation along dendrites (Rotaru et al., 2007). Electro-
physiological and Ca2+ imaging experiments in deep layer
pyramidal neurons also revealed that D1-like receptor agonists
suppress dendritic Ca2+ influx through CaV1, CaV2.2, and pos-
sibly CaV2.1 via PKC or direct protein interaction (Kisilevsky
et al., 2008; Yang and Seamans, 1996; Young and Yang, 2004;
Zhou and Antic, 2012). However, other studies failed to detect
any DA modulation of dendritic Ca2+ transients evoked by
back-propagating action potentials (Gulledge and Stuart, 2003)
or reported PKA-dependent potentiation of CaV1 currents
evoked by subthreshold somatic current injection (Young and
Yang, 2004). Thus, the reported effects of D1-like receptors on
individual ionic conductances in PFC neurons are diverse and
a coherent view of the modulatory changes that underlie the
excitatory effects of these receptors has yet to emerge.
The ionic conductances that underlie themodulatory effects of
D2 receptors in PFC pyramidal neurons have not been investi-
gated as extensively. In instances in which D2-like receptor
stimulation promotes the intrinsic excitability of subpopulations
of L5 pyramidal cells, the effects have been attributed to sup-
pression of Kir channels (Dong et al., 2004) or potentiation of
CaV1 and voltage-gated Na
+ channels (Gee et al., 2012; Moore
et al., 2011; Wang and Goldman-Rakic, 2004).
Prefrontal Cortex Interneurons
One of the most consistent and striking effects of DA on PFC
pyramidal cells is a selective increase in the frequency of spon-
taneous (TTX-sensitive), but not miniature (TTX-resistant), IPSCs
and IPSPs, reflecting a net enhancement of local GABAergic
interneuron spiking activity (Gulledge and Jaffe, 2001; Kro¨ner
et al., 2007; Penit-Soria et al., 1987; Seamans et al., 2001b;
Zhou andHablitz, 1999). This effect is largely attributed to PV-ex-
pressing FS basket and chandelier cells. Indeed, in vitro studies
in PFC slices have repeatedly demonstrated that DA acting on
D1-like receptors induces a direct membrane depolarization
and increases the input resistance and excitability of themajority
of FS interneurons (Gao and Goldman-Rakic, 2003; Gao et al.,
2003; Gorelova et al., 2002; Kro¨ner et al., 2007; Towers and Hes-
trin, 2008; Trantham-Davidson et al., 2008; Zhou and Hablitz,
1999) but exerts a variable facilitatory effect on the excitability
of other non-FS interneurons (Gao et al., 2003; Gorelova et al.,
2002; Kro¨ner et al., 2007). D2 receptor agonists have occasion-
ally been reported to further promote interneuron excitability44 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.(Tseng and O’Donnell, 2004; Wu and Hablitz, 2005). In FS
interneurons, DA’s actions are mediated by PKA-dependent
suppression of leak, inward rectifying, and depolarization-acti-
vated K+ channels (Gorelova et al., 2002) and amplification of
depolarizing currents carried by HCN channels (Gorelova et al.,
2002; Trantham-Davidson et al., 2008; Wu and Hablitz, 2005).
Early studies in which GABAergic signaling is left unperturbed
had reported that DA predominantly depresses evoked and
spontaneous firing of PFC pyramidal cells in vivo (reviewed in
Seamans and Yang, 2004) and in vitro (Geijo-Barrientos and
Pastore, 1995; Gulledge and Jaffe, 1998; Zhou and Hablitz,
1999). It is now believed that the reported inhibitory effect of
DA on pyramidal neuron excitability was indirectly mediated
through GABAergic FS cells, which primarily innervate the cell
bodies, initial axon segments, and proximal dendritic shafts of
pyramidal cells and exert a powerful influence over action poten-
tial initiation and timing. Indeed, bath application of GABAA
receptor antagonists reverses the polarity of DA’s influence on
pyramidal neuron excitability, from inhibition to facilitation (Gul-
ledge and Jaffe, 2001; Zhou and Hablitz, 1999), stressing the
importance of excluding synaptic contributions to investigate
modulation of intrinsic excitability. In addition to these changes,
DA alters the release of glutamate and GABA onto pyramidal and
nonpyramidal neurons differentially based on pre- and post-
synaptic cell identity through D1- and D2-like receptors (Chiu
et al., 2010; Gao et al., 2001, 2003; Gao and Goldman-Rakic,
2003; Gonzalez-Islas and Hablitz, 2001; Penit-Soria et al.,
1987; Seamans et al., 2001b; Towers and Hestrin, 2008; Tran-
tham-Davidson et al., 2004), revealing a rich and complex array
of modulatory influences that collectively contribute to DA’s
important role in PFC function.
Future Directions
As described above, dozens of mechanisms have been identi-
fied through which DA receptors alter the properties of neurons
and synapses. However, several important challenges remain
and it is likely that many of these results will have to be revisited
with newer approaches. Conclusions from studies using strong
pharmacological activation of DA receptors will need to be
confirmed with those employing optogenetics, in which light
can be used to trigger synaptic DA release directly from dopami-
nergic axons. Early studies using this approach have demon-
strated that midbrain DA neurons additionally release glutamate
and GABA that act on ionotropic receptors in SPNs to rapidly
regulate postsynaptic excitability (Stuber et al., 2010; Tecuapetla
et al., 2010; N.X.T. and B.L.S., unpublished data), adding another
dimension to the consequences of DA neuron firing on down-
stream targets. Similarly, the effects of DA in cortex will need
to be reexamined in transgenic mice that allow for the study of
specific subsets of DA-sensitive neurons to mitigate the experi-
mental variability that has historically confused this field (e.g.,
Gee et al., 2012; Seong and Carter, 2012). These technical
approaches continue to transform our understanding of DA
action in the striatum, where decades of previous studies were
plagued by mixing data from two classes of SPNs that express
different DA receptors. Lastly, the challenge remains of trying
to understand how the results of these largely reductionist
studies explain the consequences of DA and DA receptor
Neuron
Reviewperturbation on behavior. The hope is that knowledge from these
studies, combined with data gained from more physiological
methodologies, will permit the elucidation of the cellular and
molecular means by which DA influences neural circuits.ACKNOWLEDGMENTS
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